GINS4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.813000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.906000E-01
Normal-vs-Stage2
8.779400E-01
Normal-vs-Stage3
6.507400E-01
Normal-vs-Stage4
5.789000E-01
Stage1-vs-Stage2
8.027800E-01
Stage1-vs-Stage3
7.976400E-01
Stage1-vs-Stage4
6.900000E-01
Stage2-vs-Stage3
6.360400E-01
Stage2-vs-Stage4
5.341800E-01
Stage3-vs-Stage4
8.614200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.078800E-01
Normal-vs-AfricanAmerican
8.215200E-01
Normal-vs-Asian
6.413800E-01
Caucasian-vs-AfricanAmerican
9.528400E-01
Caucasian-vs-Asian
7.103600E-01
AfricanAmerican-vs-Asian
8.243800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.488800E-01
Normal-vs-Female
9.901800E-01
Male-vs-Female
8.182100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.588000E-01
Normal-vs-Age(41-60Yrs)
9.727600E-01
Normal-vs-Age(61-80Yrs)
6.554000E-01
Normal-vs-Age(81-100Yrs)
8.835600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.759800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.013200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.189800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.940800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.654200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.075600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.581000E-01
Normal-vs-Daily Drinker
6.226000E-01
Normal-vs-Weekly Drinker
8.386200E-01
Normal-vs-Occasional Drinker
8.244200E-01
Normal-vs-Social Drinker
9.588000E-01
Non Drinker-vs-Daily Drinker
9.333800E-01
Non Drinker-vs-Weekly Drinker
3.669600E-01
Non Drinker-vs-Occasional Drinker
5.336600E-01
Non Drinker-vs-Social Drinker
3.141200E-01
Daily Drinker-vs-Weekly Drinker
3.629200E-01
Daily Drinker-vs-Occasional Drinker
5.655600E-01
Daily Drinker-vs-Social Drinker
3.796600E-01
Weekly Drinker-vs-Occasional Drinker
5.214000E-01
Weekly Drinker-vs-Social Drinker
6.314600E-01
Occasional Drinker-vs-Social Drinker
7.420600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.551800E-01
Normal-vs-Grade 2
5.952800E-01
Normal-vs-Grade 3
6.229600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.340600E-03
Grade 1-vs-Grade 3
2.011200E-04
Grade 1-vs-Grade 4
5.551800E-01
Grade 2-vs-Grade 3
4.552200E-02
Grade 2-vs-Grade 4
5.952800E-01
Grade 3-vs-Grade 4
6.229600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.656400E-01
Normal-vs-NonDiabetic
8.153400E-01
Diabetic-vs-NonDiabetic
4.023600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.270200E-01
Normal-vs-NoPancreatitis
7.459800E-01
Pancreatitis-vs-NoPancreatitis
6.563200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.058600E-01
Normal-vs-N1
8.871600E-01
N0-vs-N1
2.726000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.315600E-01
Normal-vs-TP53-NonMutant
5.030000E-01
TP53-Mutant-vs-TP53-NonMutant
4.811500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
